Organogenesis Inc. (ORGO) - Kapitalizatsiyaning foydaga nisbati

Organogenesis Inc. - ORGO emitenti grafik logotipi

Organogenesis Holdings teri o'rnini bosuvchi vositalar va ortopedik hujayra mahsulotlari savdosiga asoslangan barqaror daromad keltiradi. GURU.Markets ma'lumotlari ushbu grafikda aks etgan kompaniyaning P/E ko'rsatkichlari tebranishlari baholash dinamikasini ifodalaydi, -0.70 esa yangi darajani belgilaydi. Bu bio-muhandislik materiallarining yuqori masshtablanuvchanligi va portfelning joriy davlat sog'liqni saqlash sug'urta tizimlariga strategik moslashuvi bilan bog'liq.

Organogenesis Corp - ORGO Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 16.11.2026)

Organogenesis Holdings kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:ORGO - Organogenesis
Organogenesis Corp original mahsuloti

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi va investorlarning biznesning kelgusidagi o'sishi uchun qo'shimcha to'lov qilishga tayyorligini o'lchaydi. No-tsiklik regenerativ tibbiyot sektorida Organogenesis Holdings (ORGO) kompaniyasining fundamental P/E koeffitsiyenti kapital barqarorligini namoyish etadi, chunki jarrohlik mahsulotlariga bo'lgan barqaror talab va sug'urta to'lovlari makroiqtisodiy risklarni muvozanatlashtirib, aktiv baholanishining bashorat qilinuvchanligini ta'minlaydi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|PGNY - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ARDT (ardenthealth.com)|SEM - Narx-foyda koeffitsiyenti|Astrana Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pennant Group (PNTG)|NUTX (Nutex Health Corp) - P/E multiplikatori|P/E multiplikatori Auna Health|P/E multiplikatori SBC|Biznesning o‘zini qoplash muddati evolus.com|Community Health Systems, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SKIN (beautyhealth.com)|MDWD: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati BTMD|JYNT: P/E multiplikatori|Narx-foyda multiplikatori DCGO|PIII (P3 Health Partners Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Gain Therapeutics, Inc. GANX|Narx-foyda koeffitsiyenti EUDA (EUDA Health Holdings)|Narxning foydaga nisbati BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|CUPR: Narx-foyda multiplikatori|CCM: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AMS (American Shared Hospital Services)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp (ALBT)|Narxning foydaga nisbati DIH Holding|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc